Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/195590
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEspinosa-Velasco, María-
dc.contributor.authorReguilón, Marina D.-
dc.contributor.authorBellot, Marina-
dc.contributor.authorNadal-Gratacós, Núria-
dc.contributor.authorBerzosa, Xavier-
dc.contributor.authorGómez-Canela, Cristian-
dc.contributor.authorRodríguez-Arias, Marta-
dc.contributor.authorCamarasa García, Jordi-
dc.contributor.authorEscubedo Rafa, Elena-
dc.contributor.authorPubill Sánchez, David-
dc.contributor.authorLópez Arnau, Raúl-
dc.date.accessioned2023-03-20T12:52:17Z-
dc.date.available2023-03-20T12:52:17Z-
dc.date.issued2022-07-13-
dc.identifier.issn0278-5846-
dc.identifier.urihttp://hdl.handle.net/2445/195590-
dc.description.abstractN-ethyl-pentedrone (NEPD, 2-(ethylamino)-1-phenyl-1-pentanone) is one of the latest synthetic cathinone derivatives that emerged into the illicit drug market. This drug has psychostimulant properties and has been related with several intoxications and even fatalities. However, information about the consequences of its acute and repeated consumption is lacking. Thus, the aim of our study was to investigate the behavioral effects after both acute and repeated NEPD exposure as well as the neurochemical changes. Male OF1 mice were treated with an acute dose (1, 3 or 10 mg/kg, i.p.) or received repeated injections of these doses (twice/day, 5 days) of NEPD. Shortly after drug-exposure or during drug-withdrawal, anxiety-like behavior, aggressiveness, social interaction, depressive-like symptoms, body weight and temperature were assessed. Also, monoamine synthesis enzymes, levels of neurotransmitters and their precursors and main metabolites, as well as ΔFosB, were determined in striatum and prefrontal cortex from post-mortem tissue. Acute administration of NEPD induced anxiolytic effects and reduced social exploration whereas during withdrawal after repeated administration the anxiolytic effect had vanished, and the reduced social exploration was still present and accompanied with increased aggressive behavior. Moreover, NEPD (10 mg/kg) induced slight hyperthermia and reduced weight gain during the repeated administration, whereas increased locomotor activity and lack of depressive symptoms were found during withdrawal. This was accompanied by increased plasma corticosterone and decrease in striatal dopamine. Finally, the long-lasting and robust increase in ΔFosB levels found in striatum after NEPD chronic exposure suggests a high risk of dependence. The increased aggressivity and locomotor activity, together with this potential of inducing dependence justify a warning about the risks of consumption of NEPD if translated to humans. Keywords: Addiction; Aggressive behavior; Monoamine levels; N-ethyl-pentedrone; Synthetic cathinones.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.pnpbp.2022.110562-
dc.relation.ispartofProgress in Neuro-Psychopharmacology & Biological Psychiatry, 2022, vol. 117-
dc.relation.urihttps://doi.org/10.1016/j.pnpbp.2022.110562-
dc.rightscc-by-nc-nd (c) María Espinosa-Velasco, et al., 2022-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationDrogues-
dc.subject.classificationEstimulants-
dc.subject.classificationAgressivitat-
dc.subject.otherDrugs of abuse-
dc.subject.otherStimulants-
dc.subject.otherAggressiveness-
dc.titleRepeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec723569-
dc.date.updated2023-03-20T12:52:17Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Institut de Biomedicina (IBUB))
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
723569.pdf3.52 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons